NCT06354842

Measurement of Sweat Sodium Concentration in Patients With Chronic Kidney Disease

Application of Pilocarpine Iontophoresis in Patients With Chronic Kidney Disease: a Feasibility Study
Medical University of Vienna·ClinicalTrials.gov·diagnostic testCompleted
View on ClinicalTrials.gov
Study focus
Disease/Condition
Chronic Kidney Diseases
Drug/Device/Intervention
pilocarpine iontopheresis
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Medical University of Vienna
Location
Vienna, Austria
Timeline & enrollment
Phase
N/A
Start date
Oct 05, 2018
End date
Dec 11, 2020
Enrollment
64 participants
Primary outcome

Sweat sodium concentration

Summary

It has been shown that excretion of sodium and water through the skin in the form of sweat
 represents a regulatory mechanism of electrolyte- and fluid balance. Since patients with
 chronic kidney disease (CKD) exhibit increased skin sodium content, we investigated the
 feasibility of sweat testing as a novel experimental tool to a more complete assessment of
 fluid- and sodium homeostasis.
 
 In this cross-sectional feasibility study, we applied pilocarpine iontophoresis to induce
 sweat testing in 58 patients across various stages of CKD including patients after kidney
 transplantation as well as a healthy control cohort (n=6) to investigate possible effects of
 CKD and transplantation status on sweat rate and sodium concentration. Due to non-linear
 relationships, we modeled our data using polynomial regression.
 
 Decline of kidney function showed a significant association with lower sweat rates: adj R²=
 0.2278, F(2, 61) = 10.29, p = 0.000141. Sweat sodium concentrations were increased in
 moderate CKD, however this effect was lost in end stage renal disease: adj R² = 0.3701, F(4,
 59) = 10.26, p = 2.261e-06. We observed higher sweat weight in males compared to females.
 
 Diagnostic sweat analysis represents an innovative and promising noninvasive option for more
 thorough investigation of sodium- and fluid homeostasis in CKD patients. Lower sweat rates
 and higher sweat sodium concentrations represent a unique feature of CKD patients with
 potential therapeutic implications.

ICD-10 classifications
Chronic kidney diseaseChronic kidney disease, unspecifiedChronic kidney disease, stage 1Chronic kidney disease, stage 4Chronic kidney disease, stage 2
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06354842
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06354842 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical University of Vienna and is currently Completed. The study focuses on Chronic Kidney Diseases. Target enrollment is 64 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.